• OPEN AN ACCOUNT
Indian Indices
Nifty
24,008.00 -265.80
(-1.10%)
Sensex
79,454.47 -880.34
( -1.10%)
Bank Nifty
53,595.25 -770.40
( -1.42%)
Nifty IT
35,880.10 -122.35
( -0.34%)
Global Indices
Nasdaq
41,266.30 -123.15
(-0.30%)
Dow Jones
5,680.75 -4.19
(-0.07%)
Hang Seng
37,492.25 563.62
(1.53%)
Nikkei 225
8,554.80 23.19
(0.27%)
Forex
USD-INR
85.39 0.69
(0.81%)
EUR-INR
96.28 0.21
(0.22%)
GBP-INR
113.48 0.52
(0.46%)
JPY-INR
0.59 0.00
(-0.21%)

EQUITY - MARKET SCREENER

Divis Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
532488
INE361B01024
513.6236355
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DIVISLAB
76.85
159310.35
EPS(TTM)
Face Value()
Div & Yield %
78.09
2
0.5
 

divis laboratories ltd
Divis Laboratories enters into long term manufacturing and supply agreement
Apr 18,2025
Divis Laboratories has signed a long term manufacturing and supply agreement with a global pharma company. Under the agreement, the company will manufacture and supply advance intermediates as per the commercial terms agreed between the parties. The company is planning to increase its manufacturing capacity with an estimated investment of Rs 650-700 crore to be funded from internal accruals.